Poster No:
595
Submission Type:
Abstract Submission
Authors:
Nils Winter1, Katharina Förster2, Thomas Frodl3, Klaus Berger4, Philipp Kanske5, Jan Ernsting6, Ramona Leenings7, Carlotta Barkhau7, Maximilian Konowski1, Lukas Fisch7, Daniel Emden7, Udo Dannlowski7, Tim Hahn7, Dominik Grotegerd8
Institutions:
1University of Münster, Münster, North-Rhine Westphalia, 2University of Dresden, Dresden, Saxony, 3RWTH Aachen University, Aachen, North-Rhine Westphalia, 4Institute of Epidemiology and Social Medicine, University of Münster, Münster, NRW, Germany, 5Clinical Psychology and Behavioral Neuroscience, Technische Universität Dresden, Dresden, Germany, 6University of Münster, Münster, NRW, 7Institute for Translational Psychiatry, Münster, North Rhine Westphalia, 8Institute for Translational Psychiatry, University of Münster, Münster, North Rhine-Westphalia
First Author:
Nils Winter
University of Münster
Münster, North-Rhine Westphalia
Co-Author(s):
Thomas Frodl
RWTH Aachen University
Aachen, North-Rhine Westphalia
Klaus Berger
Institute of Epidemiology and Social Medicine, University of Münster
Münster, NRW, Germany
Philipp Kanske
Clinical Psychology and Behavioral Neuroscience, Technische Universität Dresden
Dresden, Germany
Ramona Leenings
Institute for Translational Psychiatry
Münster, North Rhine Westphalia
Carlotta Barkhau
Institute for Translational Psychiatry
Münster, North Rhine Westphalia
Lukas Fisch
Institute for Translational Psychiatry
Münster, North Rhine Westphalia
Daniel Emden
Institute for Translational Psychiatry
Münster, North Rhine Westphalia
Udo Dannlowski
Institute for Translational Psychiatry
Münster, North Rhine Westphalia
Tim Hahn
Institute for Translational Psychiatry
Münster, North Rhine Westphalia
Dominik Grotegerd
Institute for Translational Psychiatry, University of Münster
Münster, North Rhine-Westphalia
Introduction:
Affective disorders contribute immensely to the global burden of disease worldwide (Murray et al., 2012; Paykel et al., 2005). Recently, a novel multivariate biomarker has emerged in the field of neuroimaging that aims at quantifying the age-associated biological changes that occur in the brain (Cole et al., 2019). The underlying hypothesis of the brain age prediction paradigm is that this brain age gap (BAG) may serve as a marker of disease risk and there are a number of studies emphasizing an association between brain age gaps and clinically relevant variables (Bittner et al., 2021; Elliott et al., 2019). We investigated associations of the brain age gap with disease course over nine years in patients with affective disorders in a long-term prospective design.
Methods:
At two time-points, we acquired T1-weighted MRI images (mean [SD] follow-up period 8.98 [2.20] years) of patients with affective disorders (N = 38) and healthy controls (HC: N = 37) at two sites (Dublin, UK; Münster, Germany). Using a publicly available, uncertainty-aware brain age prediction model trained on a sample of over 10,000 individuals of the German National Cohort (GNC), we estimated individual BAG at two time-points (baseline and follow-up) using gray matter segments derived from MRI images (Hahn et al., 2022). In short, in contrast to existing brain age models, the MCCQR-NN model provides accurate estimations of predictive uncertainty in high-dimensional neuroimaging data while ensuring state-of-the-art model performance. It is therefore especially suited for the detection of subtle brain age changes, e.g., in clinical cohorts. Employing linear-mixed-effects models, we tested main effects of diagnosis at follow-up and hospitalizations during follow-up on BAG at baseline and follow-up, as well as the interaction of diagnosis and hospitalization with time respectively. In an exploratory analysis, we tested if BAG at baseline was predictive of further hospitalizations during the nine-year follow-up using logistic regression and 10-fold nested cross-validation. All brain age predictions and machine learning analyses were made using the Python package PHOTONAI (Leenings et al., 2021).
Results:
MDD patients showed a larger BAG compared to HC (MDD>HC: p=.039, MDD vs. BD: n.s.), while BD patients only showed a tendency for a larger BAG (p=.066). In the Münster subsample (N=52), patients with hospitalizations showed a higher BAG compared to patients without hospitalizations (p=.001). No significant group-by-time interaction could be detected.
However, an increased baseline BAG was linked to the number of hospitalizations during follow-up (p=.018). Employing machine learning to predict hospitalization based on the baseline BAG resulted in a classification accuracy of 64.3%, yet this did not reach statistical significance.
Conclusions:
Using a state-of-the-art brain age prediction model trained on T1-weighted MRI images of 10,000 individuals, we calculated and compared brain age gaps in a sample of 75 patients with affective disorders and healthy controls, measured at two time points with a mean follow-up length of nine years. Our results show that BAG did not change over time as a function of patients' course of disease. The present study rather suggests that a higher estimation of biological ageing (higher BAG) predicts future hospitalizations. Therefore, BAG may indicate a patient's vulnerability to future recurrence.
Disorders of the Nervous System:
Psychiatric (eg. Depression, Anxiety, Schizophrenia) 1
Modeling and Analysis Methods:
Classification and Predictive Modeling 2
Multivariate Approaches
Novel Imaging Acquisition Methods:
Anatomical MRI
Keywords:
Affective Disorders
Aging
Machine Learning
MRI
Psychiatric Disorders
1|2Indicates the priority used for review
Provide references using author date format
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S.,
Aboyans, V., Abraham, J., Ackerman, I., Aggarwal, R., Ahn, S. Y., Ali, M. K., Alvarado, M., Anderson, H. R., Anderson, L. M., … Memish, Z. A. (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380(9859), 2197–2223.
Paykel, E. S., Brugha, T., & Fryers, T. (2005). Size and burden of depressive disorders in Europe. European
Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 15(4), 411–423.
Cole, J. H., Marioni, R. E., Harris, S. E., & Deary, I. J. (2019). Brain age and other bodily ‘ages’: Implications for neuropsychiatry.
Molecular Psychiatry, 24(2), 266–281.
Bittner, N., Jockwitz, C., Franke, K., Gaser, C., Moebus, S., Bayen, U. J., Amunts, K., & Caspers, S. (2021). When your brain looks
older than expected: Combined lifestyle risk and BrainAGE. Brain Structure & Function, 226(3), 621–645.
Elliott, M. L., Belsky, D. W., Knodt, A. R., Ireland, D., Melzer, T. R., Poulton, R., Ramrakha, S., Caspi, A., Moffitt, T. E., & Hariri, A.
R. (2019). Brain-age in midlife is associated with accelerated biological aging and cognitive decline in a longitudinal birth cohort. Molecular Psychiatry, 1–10.
Hahn, T., Ernsting, J., Winter, N. R., Holstein, V., Leenings, R., Beisemann, M., Fisch, L., Sarink, K., Emden, D., Opel, N., Redlich,
R., Repple, J., Grotegerd, D., Meinert, S., Hirsch, J. G., Niendorf, T., Endemann, B., Bamberg, F., Kröncke, T., … Berger, K. (2022). An uncertainty-aware, shareable, and transparent neural network architecture for brain-age modeling. Science Advances.
Leenings, R., Winter, N. R., Plagwitz, L., Holstein, V., Ernsting, J., Sarink, K., Fisch, L., Steenweg, J., Kleine-Vennekate, L., Gebker,
J., Emden, D., Grotegerd, D., Opel, N., Risse, B., Jiang, X., Dannlowski, U., & Hahn, T. (2021). PHOTONAI—A Python API for rapid machine learning model development. PLOS ONE, 16(7), e0254062.